NANOG(n, %) | ||||
---|---|---|---|---|
Variables | case | Low(215) | High(94) | p a |
Gender | ||||
Male | 134 | 90(67.2) | 44(32.8) | 0.419 |
Female | 175 | 125(71.4) | 50(28.6) | |
Age (years)b | ||||
<52 | 149 | 99(66.4) | 50(33.6) | 0.248 |
≥52 | 160 | 116(72.5) | 44(27.5) | |
Histologic subtype | ||||
Squamous carcinoma | 142 | 103(72.5) | 39(27.5) | 0.298 |
Adenocarcinoma | 167 | 112(67.1) | 55(32.9) | |
Histologicalgrade | ||||
Grade 1 | 126 | 105(83.3) | 21(16.7) | <0.001 |
Grade 2 | 112 | 80(71.4) | 32(28.6) | |
Grade 3 | 71 | 30(42.3) | 41(57.7) | |
T classification | ||||
T1 | 71 | 50(70.4) | 21(29.6) | 0.572 |
T2 | 58 | 36(62.1) | 22(37.9) | |
T3 | 126 | 91(72.2) | 35(27.8) | |
T4 | 54 | 38(70.4) | 16(29.6) | |
Clinical stage | 0.358 | |||
I | 108 | 75(69.4) | 33(30.6) | |
II | 81 | 61(75.3) | 20(24.7) | |
III | 120 | 79(65.8) | 41(34.2) |